Logo image of BELYS.BR

BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

Europe - EBR:BELYS - BE0974314461 - Common Stock

0.925 EUR
0 (0%)
Last: 10/24/2025, 7:00:00 PM
Fundamental Rating

3

BELYS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 34 industry peers in the Household Durables industry. BELYS may be in some trouble as it scores bad on both profitability and health. BELYS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BELYS has reported negative net income.
In the past year BELYS had a positive cash flow from operations.
BELYS had negative earnings in 4 of the past 5 years.
Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

BELYS has a Return On Assets of -0.02%. This is in the lower half of the industry: BELYS underperforms 61.76% of its industry peers.
The Return On Equity of BELYS (-0.07%) is worse than 61.76% of its industry peers.
BELYS has a better Return On Invested Capital (6.45%) than 67.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BELYS is below the industry average of 10.91%.
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROIC 6.45%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

BELYS has a Operating Margin of 6.91%. This is in the better half of the industry: BELYS outperforms 70.59% of its industry peers.
In the last couple of years the Operating Margin of BELYS has declined.
With an excellent Gross Margin value of 61.34%, BELYS belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
BELYS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.91%
PM (TTM) N/A
GM 61.34%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BELYS is destroying value.
Compared to 1 year ago, BELYS has about the same amount of shares outstanding.
BELYS has a better debt/assets ratio than last year.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BELYS has an Altman-Z score of 0.28. This is a bad value and indicates that BELYS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.28, BELYS is doing worse than 82.35% of the companies in the same industry.
BELYS has a debt to FCF ratio of 5.07. This is a neutral value as BELYS would need 5.07 years to pay back of all of its debts.
BELYS has a better Debt to FCF ratio (5.07) than 73.53% of its industry peers.
A Debt/Equity ratio of 1.80 is on the high side and indicates that BELYS has dependencies on debt financing.
With a Debt to Equity ratio value of 1.80, BELYS is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 5.07
Altman-Z 0.28
ROIC/WACC0.59
WACC10.96%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

BELYS has a Current Ratio of 1.63. This is a normal value and indicates that BELYS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.63, BELYS perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
BELYS has a Quick Ratio of 1.63. This is a bad value and indicates that BELYS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BELYS (0.90) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.9
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

The earnings per share for BELYS have decreased strongly by -100.58% in the last year.
BELYS shows a decrease in Revenue. In the last year, the revenue decreased by -6.81%.
BELYS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.43% yearly.
EPS 1Y (TTM)-100.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%

3.2 Future

Based on estimates for the next years, BELYS will show a decrease in Earnings Per Share. The EPS will decrease by -1.41% on average per year.
The Revenue is expected to grow by 0.36% on average over the next years.
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

BELYS is valuated cheaply with a Price/Forward Earnings ratio of 4.99.
97.06% of the companies in the same industry are more expensive than BELYS, based on the Price/Forward Earnings ratio.
BELYS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.99
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

91.18% of the companies in the same industry are more expensive than BELYS, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BELYS indicates a rather cheap valuation: BELYS is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.07
EV/EBITDA 4.03
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%

0

5. Dividend

5.1 Amount

No dividends for BELYS!.
Industry RankSector Rank
Dividend Yield N/A

BELYSSE GROUP NV

EBR:BELYS (10/24/2025, 7:00:00 PM)

0.925

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)09-05 2025-09-05
Earnings (Next)10-20 2025-10-20
Inst Owners13.5%
Inst Owner ChangeN/A
Ins Owners5.56%
Ins Owner ChangeN/A
Market Cap33.24M
Revenue(TTM)270.29M
Net Income(TTM)-55000
Analysts84.44
Price Target1.63 (76.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)16.67%
EPS NY rev (3m)-30%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.99
P/S 0.12
P/FCF 1.07
P/OCF 0.81
P/B 0.41
P/tB N/A
EV/EBITDA 4.03
EPS(TTM)0
EYN/A
EPS(NY)0.19
Fwd EY20.04%
FCF(TTM)0.86
FCFY93.37%
OCF(TTM)1.14
OCFY122.96%
SpS7.52
BVpS2.28
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROCE 7.87%
ROIC 6.45%
ROICexc 7.62%
ROICexgc 15.63%
OM 6.91%
PM (TTM) N/A
GM 61.34%
FCFM 11.48%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexgc growth 3Y21.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 5.07
Debt/EBITDA 3.85
Cap/Depr 50.25%
Cap/Sales 3.64%
Interest Coverage 1.3
Cash Conversion 106.91%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.9
Altman-Z 0.28
F-Score4
WACC10.96%
ROIC/WACC0.59
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A
EBIT growth 1Y-18.87%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year68.18%
EBIT Next 3Y25.03%
EBIT Next 5YN/A
FCF growth 1Y111.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.84%
OCF growth 3YN/A
OCF growth 5YN/A

BELYSSE GROUP NV / BELYS.BR FAQ

What is the fundamental rating for BELYS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BELYS.BR.


What is the valuation status for BELYS stock?

ChartMill assigns a valuation rating of 5 / 10 to BELYSSE GROUP NV (BELYS.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for BELYSSE GROUP NV?

BELYSSE GROUP NV (BELYS.BR) has a profitability rating of 3 / 10.


Can you provide the financial health for BELYS stock?

The financial health rating of BELYSSE GROUP NV (BELYS.BR) is 3 / 10.